IXC.AX
Price:
$0.12
Market Cap:
$9.02M
Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial. The company was incorporated in 2019 and is based in Perth, Australia.
Industry
Biotechnology
IPO Date
2019-07-05
Stock Exchange
ASX
Ticker
IXC.AX
According to Invex Therapeutics Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 24.79. This represents a change of 72.24% compared to the average of 14.39 of the last 4 quarters.
The mean historical Current Ratio of Invex Therapeutics Ltd over the last ten years is 22.68. The current 24.79 Current Ratio has changed 10.83% with respect to the historical average. Over the past ten years (40 quarters), IXC.AX's Current Ratio was at its highest in in the December 2020 quarter at 53.07. The Current Ratio was at its lowest in in the December 2023 quarter at 6.38.
Average
22.68
Median
14.50
Minimum
13.10
Maximum
49.71
Discovering the peaks and valleys of Invex Therapeutics Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 279.21%
Maximum Annual Current Ratio = 49.71
Minimum Annual Increase = -50.61%
Minimum Annual Current Ratio = 13.10
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 24.79 | 74.82% |
| 2024 | 14.18 | -2.23% |
| 2023 | 14.50 | -50.61% |
| 2022 | 29.36 | -40.93% |
| 2021 | 49.71 | 279.21% |
| 2020 | 13.11 | 0.05% |
The current Current Ratio of Invex Therapeutics Ltd (IXC.AX) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
17.82
5-year avg
26.51
10-year avg
22.68
Invex Therapeutics Ltd’s Current Ratio is greater than Bio-Gene Technology Limited (3.86), greater than Vectus Biosystems Limited (0.93), greater than Memphasys Limited (0.25), greater than Percheron Therapeutics Limited (5.10), greater than Intelicare Holdings Limited (1.39), greater than Chimeric Therapeutics Limited (0.72), greater than Biotron Limited (2.23), greater than Acrux Limited (1.07), greater than Cann Group Limited (0.12), greater than Adherium Limited (0.41),
| Company | Current Ratio | Market cap |
|---|---|---|
| 3.86 | $7.93M | |
| 0.93 | $5.87M | |
| 0.25 | $9.82M | |
| 5.10 | $7.61M | |
| 1.39 | $10.52M | |
| 0.72 | $12.75M | |
| 2.23 | $4.98M | |
| 1.07 | $6.57M | |
| 0.12 | $5.63M | |
| 0.41 | $7.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Invex Therapeutics Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Invex Therapeutics Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Invex Therapeutics Ltd's Current Ratio?
How is the Current Ratio calculated for Invex Therapeutics Ltd (IXC.AX)?
What is the highest Current Ratio for Invex Therapeutics Ltd (IXC.AX)?
What is the 3-year average Current Ratio for Invex Therapeutics Ltd (IXC.AX)?
What is the 5-year average Current Ratio for Invex Therapeutics Ltd (IXC.AX)?
How does the current Current Ratio for Invex Therapeutics Ltd (IXC.AX) compare to its historical average?